Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -5.83M | -6.04M | -5.98M | -5.99M | -6.31M | -5.03M | -5.13M | -4.23M | -3.68M | -4.09M | -4.51M | -26.77M | -27.57M | -27.21M | -26.74M | -2.57M | -5.15M | -7.49M | -12.44M | -14.19M | -10.85M | -8.87M |
Depreciation & Amortization | 349.58K | 344.14K | 332.07K | 298.89K | 267.36K | 245.7K | 223.53K | 200.48K | 173.04K | 157.05K | 149.14K | 125.77K | 89.36K | 56.76K | 25.16K | 9.37K | 11.76K | 12.67K | 12.74K | 13.12K | 13.44K | 13.42K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 316.35K | 532.47K | 498.67K | 2.47M | 2.87M | 2.19M | 1.53M | 437.64K | -1.21M | -879.9K | -94.39K | -685.35K | 378.96K | 506.86K | 276.87K | -79.38K | -90.99K | -79.55K | -2.88K | 25.42K | 17.75K | 10.18K |
Other Non-Cash Items | 376.98K | 1.78M | 1.78M | -618.3K | -1.19M | -4.8M | -4.78M | -2.53M | -1.45M | 12K | 3 | 18.33M | 17.24M | 18.32M | 18.32M | -914.51K | 2.58M | 4.92M | 10.7M | 12.26M | 9.39M | 7.9M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -227.77K | -1.77M | -1.44M | -791.47K | -507.19K | -1.46M | -2.83M | -5.25M | -5.95M | -6.19M | -4.42M | -16.33K | 1.24M | 3.04M | 3.15M | 156.29K | -236.82K | -279.86K | -108.8K | -29.58K | -13.07K | 42.63K |
Operating Cash Flow | -5.33M | -5.69M | -5.31M | -7.1M | -7.73M | -11.04M | -12.53M | -11.81M | -10.91M | -10.11M | -8.78M | -8.33M | -9M | -5.79M | -5.25M | -3.31M | -2.79M | -2.84M | -1.83M | -1.94M | -1.46M | -923.62K |
Capital Expenditures | 736.1K | 180.78K | -26.1K | -1.24M | -1.81M | -1.83M | -2.32M | -1.5M | -901.45K | -623.46K | -102.05K | -678.4K | 457.13K | 1.33M | 1.5M | 1.7M | 573.8K | 1 | -2 | -396 | -394 | -396 |
Cash Acquisitions | -10.25K | -10.25K | -10.25K | n/a | n/a | n/a | n/a | 34.45K | 34.45K | 34.45K | 33.32K | -14.31M | -14.31M | -14.31M | -14.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -435.38K | -657.52K | -862.05K | -733.96K | -777.3K | -13.22K | -414.49K | -327.09K | -145K | -542.55K | 96.47K | 95.34K | 66.85K | 32.09K | -1.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -278.14K | -764.8K | -872.3K | -1.35M | -1.91M | -1.96M | -2.41M | -2.15M | -1.46M | -1.18M | -656.15K | -15.01M | -15.03M | -14.77M | -14.62M | n/a | n/a | n/a | n/a | -391 | -1.19K | -1.19K |
Debt Repayment | n/a | -58.38K | -75.54K | 360.25K | 330.59K | 360.39K | 347.94K | -87.85K | -87.45K | -91.26K | -93.13K | -2.19M | -45.62M | -16.56M | -18.43M | -16.36M | 28.38M | -97.33K | 2.9M | 3.81M | 3.06M | 2.67M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -3.14M | -3.14M | -3.17M | -3.17M | -541.14K | -541.14K | -506.82K | -506.82K | -99K | -99K | -99K | -99K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.88M | 75.54K | 92.7K | 92.7K | 105.01K | 105.01K | 132.85K | 99.99K | 12.14K | 13.29K | -31.71K | 13.19M | 13.1M | 13.19M | 13.29M | 99K | 198K | 99K | n/a | 40.61K | 40.61K | 40.61K |
Financial Cash Flow | 8.6M | 4.41M | 4.77M | 6.1M | 7.97M | 4.33M | 9.38M | 7.29M | 5.28M | 9.36M | 3.43M | 1.36M | 1.42M | 26.49M | 39.47M | 41.54M | 42.81M | 14.24M | 2.9M | 3.85M | 3.1M | 2.71M |
Net Cash Flow | 3.44M | -1.21M | -563.22K | -2.9M | -1.2M | -9.31M | -6.61M | -6.64M | -8.22M | -1.86M | -5.53M | -21.71M | -22M | 6.12M | 19.78M | 38.17M | 39.99M | 11.38M | 1.06M | 1.9M | 1.65M | 1.79M |
Free Cash Flow | -4.6M | -5.51M | -5.34M | -8.34M | -9.54M | -12.87M | -14.85M | -13.31M | -11.81M | -10.73M | -8.88M | -9.01M | -9.67M | -6.17M | -5.44M | -3.31M | -2.79M | -2.84M | -1.83M | -1.94M | -1.46M | -924.82K |
Adj. Free Cash Flow | -4.6M | -5.51M | -5.34M | -8.34M | -9.54M | -12.87M | -14.85M | -13.31M | -11.81M | -10.73M | -8.88M | -9.01M | -9.67M | -6.17M | -5.44M | -3.31M | -2.79M | -2.84M | -1.83M | -1.94M | -1.46M | -924.82K |
Maintenance CapEx | 759.98K | 220.34K | 82.12K | -1.01M | -1.46M | -1.26M | -1.65M | -621.54K | -165.8K | 174.14K | 709.65K | n/a | 1.15M | 1.75M | 1.75M | 1.75M | 603.32K | 10 | 10 | 4 | 4 | n/a |
Growth CapEx | -23.88K | -39.55K | -108.22K | -227.07K | -346.71K | -573.58K | -669.21K | -877.64K | -735.65K | -797.6K | -811.7K | -678.4K | -691.57K | -426.86K | -248.46K | -54.49K | -29.52K | -9 | -12 | -400 | -398 | -396 |
Owner Earnings | -4.57M | -5.47M | -5.23M | -8.11M | -9.2M | -12.3M | -14.18M | -12.43M | -11.08M | -9.94M | -8.07M | -8.33M | -7.85M | -4.04M | -3.5M | -1.56M | -2.19M | -2.84M | -1.83M | -1.94M | -1.46M | -923.62K |
Add to Watchlist
Select watchlists to add or remove SBFM